Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03884335
Other study ID # 16/42
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2016
Est. completion date July 18, 2018

Study information

Verified date March 2019
Source Consorci Sanitari Integral
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Current trends are based on the implementation of enhanced recovery programs (ERP) for most surgical procedures. The transversus abdominis plane (TAP) block has been demonstrated as an effective analgesic alternative in abdominal surgeries. The goal of this study was to compare analgesic efficacy of the TAP block against epidural technique in patients who underwent laparoscopic radical prostatectomy (LRP) surgery in an ERP setting. This study was performed between October 2016 and May 2018


Description:

After approval from Institutional Review Board (approval number 16/42) and compliance with the Declaration of Helsinki; and complying with the information checklist of Consolidated Standards of Reporting trials (CONSORT), informed consent was obtained from all those patients who underwent LRP between October 2016 and May 2018.

Exclusion criteria were: age below 18 years old; American Society of Anaesthesiologists (ASA) score ≥IV; body mass index (BMI) ≥30 Kg/m-2; history of local anaesthetic (LA) allergies; chronic opioid use, coagulopathy; peripheral neuropathy; reconversion to open surgery; or patient's refusal of consent.

Patients were randomized to either TAP or epidural group according to sequential recruitment criteria performed at the pre-operative visit. At this point, age, anaesthesia ASA score and BMI was also recorded.

Management of patients undergoing LRP - intraoperatively All patients underwent combined anaesthesia: either general anaesthesia + epidural; or general anaesthesia + TAP block (TAP group). Patients were premedicated with intravenous midazolam 0.05 mg/Kg-1. In the epidural group, a catheter was placed at L1-L2 level, and tested, prior to induction. Induction was performed intravenously with fentanyl (1.5 mcg/Kg-1), propofol (1.5-2 mg/Kg-1), and rocuronium (0.6 mg/Kg-1). Orotracheal intubation was performed. Prior to skin incision 8 mL of 0.25% levo-bupivacaine were administered epidurally, and a continuous perfusion of 0.125% levo-bupivacaine at 5 mL was started. In the TAP group, a bilateral, ultrasound-guided mid-axillary TAP block was performed immediately after induction (the same as epidural group) but prior to surgery. The high-frequency lineal probe (Sonosite MicroMAXXTM) was placed midway between the costal margin and iliac crest, and transversus abdominis muscle (TAM) located behind the rectus abdominis and below the internal oblique muscle (IOM). 20 mL of LA (bupivacaine 0.375%) was administered via a 22-gauge Quincke spinal needle inserted in-plane on each side of the abdomen. A block was considered successful whenever interfascial local anaesthetic spread was evident under ultrasound vision.

A laparoscopic radical prostatectomy was performed. Intraoperative anaesthetic maintenance was performed with propofol target-controlled infusion (TCI) for bispectral index between 40 and 60. Net zero fluid therapy was maintained, as well as normothermia, normotension and optimal intraoperative analgesia following ERP criteria. After surgery, patients were awoken from general anaesthesia and transferred to the post-anaesthesia care unit (PACU) for a 6-hour follow-up prior to transfer to conventional ward.

The following data was recorded during the intraoperative period: hemodynamic and respiratory parameters, complications related to analgesic technique (vascular puncture, peritoneal or intestinal puncture in the TAP block, number of attempts, impossibility to perform technique), surgery-related complications (bleeding, intestinal, bladder or diaphragmatic perforation), and length of surgery.

Management of patients undergoing LRP - PACU. In the PACU, the patient was kept under observation for 6 hours for pain and bleeding control, as well as hemodynamic and respiratory management. Besides epidural or TAP blockade, standard analgesia was maintained with paracetamol 1g/8h/iv alternate with metamizole 2 g/8h/iv, as well as 2 mg bolus of morphine, if required. If pain was unmanageable, in the epidural group the first option was administration of 8 mL of 0.125% levo-bupivacaine, secondly catheter was re-positioned, and if these options failed, catheter was removed and a morphine infusion was begun. In the TAP group, if rescue morphine bolus (of up to 10mg) was not enough, TAP-block was repeated. If after 20 minutes the patient showed no improvement, morphine infusion was begun. In these cases (both epidural and TAP groups), data was considered as analgesic technique failure.

The following data was recorded during the PACU period: pain as evaluated by the visual analogue scale (VAS) upon rest (VASr) and movement -cough- (VASm) at 1, 2, 3, 4, and 6 hours; mg of morphine administered; failure of analgesic technique (need of morphine PCA); surgical complications; analgesic technique complications (motor blockade, paraesthesias, accidental catheter disconnection); hydric tolerance; postoperative nausea or vomiting (PONV); and time to bowel movement (first flatus after surgery).

Management of patients undergoing LRP - Hospital Ward. After PACU, patients were transferred to conventional hospital ward. During this period, they were followed-up by the hospital's acute pain team, formed by an anaesthesiologist and a specialized nurse.

The following data was registered during this period: VASr and VASm at 12, 18, 24, 36, and 48 hours; time to sitting position and perambulation; PONV; complications of surgical and anaesthetic technique (including infection at this point); mg of morphine administered; failure of analgesic technique (need of morphine PCA); and length of in-hospital stay.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date July 18, 2018
Est. primary completion date May 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All patients undergoing laparoscopic radical prostatectomy

Exclusion Criteria:

- anaesthesia ASA score =IV;

- body mass index (BMI) =30 Kg/m2;

- history of local anaesthesic (LA) allergies, -

- chronic opioid use,

- coagulation alterations (including heparin treatment)

- peripheral neuropathy;

- reconversion to open surgery;

- patient's refusal of consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
laparoscopic radical prostatectomy
The surgery was carried out by laparoscopy. Intraoperative anesthetic maintenance was performed with TCI of propofol infusion for bispectral index between 40 and 60, restrictive administration of fluids or goal-directed parenteral fluid administration, normothermia, normotension and optimal intraoperative analgesia were maintained following the criteria of ERP. Afterwards, patients were awoken from general anaesthesia and transferred to the post-anaesthesia care unit (PACU) for a 6-hour follow-up prior to transfer to conventional ward.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Consorci Sanitari Integral

Outcome

Type Measure Description Time frame Safety issue
Primary Evolution of postoperative pain over time Pain was evaluated by the visual analogue scale (VAS) upon rest (VASr) and movement -cough- (VASm) at postanesthesia care unit and in the hospital ward. VAS ranges from 0 (no pain) to 10 (maximum pain). Pain was assessed at 1 hour, 2 hours, 3 hours, 4 hours, and 6 hours, and then 12 hours,18 hours, 24 hours, 36 hours and 48 hours
Secondary Need for postoperative analgesic medication milligrams of morphine administered up to 6 hours after surgery
Secondary Postoperative recovery time to bowel movement (first flatus after surgery) up to 24 hours postoperatively
Secondary Evolution till hospital discharge time to sitting position and perambulation up to 48 hours postoperatively
See also
  Status Clinical Trial Phase
Completed NCT02924974 - Spinal Morphine in Robotic Assisted Radical Prostatectomy Phase 4
Completed NCT02369211 - Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) Phase 4
Recruiting NCT04933084 - Pre-operative Education Modalities to Decrease Opioid Use N/A
Completed NCT06020287 - The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
Active, not recruiting NCT04172519 - Pelvic Floor Muscles Training After Radical Prostatectomy. N/A
Not yet recruiting NCT05576766 - Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy N/A
Terminated NCT01008709 - Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery N/A
Completed NCT03714984 - The Efficacy of Pre-operative Educational Pelvic Floor Intervention on Urinary Continence N/A
Recruiting NCT06274125 - Evaluation of Kidney Damage Using NGAL Measurements
Completed NCT03721029 - Intraoperative Nerve Monitoring During Robotic-assisted Radical Prostatectomy N/A
Withdrawn NCT02621684 - Physical Activity Intervention in African American Men After Radical Prostatectomy N/A
Completed NCT06119568 - Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP N/A
Recruiting NCT04261777 - Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients Phase 3
Recruiting NCT03080116 - Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy Phase 2
Recruiting NCT05008900 - Timing of Post-prostatectomy PSMA Imaging Phase 2
Completed NCT01582477 - TAP-patients With Robotic Assisted Lap Prostatectomy Phase 4
Completed NCT05242198 - Rectus Sheath Block May Relieve Urethral Catheter Pain N/A
Not yet recruiting NCT03061760 - Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy N/A
Recruiting NCT04404738 - MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology N/A
Recruiting NCT02485665 - Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence N/A